StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
AbbVie (ABBV): Cutting PT Slightly After Earnings - Leerink
October 30, 2017 7:59 AM
Leerink Partners analyst, Geoffrey Porges, reiterated his Outperform rating on shares of Abbvie (NYSE: ABBV) and cut his price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Call Buying Activity in AbbVie (ABBV) Targets 3% Upside in Shares Into Mid-November Ahead Various Drug Trials -Susquehanna
October 30, 2017 2:39 PM